DocGo Inc.

NASDAQ:DCGO

Medical - Care Facilities

Healthcare
$0.71 -4.29%

-$0.02 today

Market cap
$70.14M
Beta
1.00
P/E (TTM)
-0.3
EPS (TTM)
-$1.90
52W Low $0.49High $1.78

Volume 1.64M

Average 0.87M

DCGO Change in Working Capital

Cash absorbed or released by changes in receivables, inventory, payables, and other operating balances.

DocGo Inc.NASDAQ: DCGO

Change in Working Capital · Q1 FY2026 · quarter ended Mar 2026

Change in working capital dips below year-ago levels

Q1 FY2026 change in working capital of $1.95M fell 86.8% year over year, behind the +5.9% change in trailing-twelve-month change in working capital. Sequentially, it fell 75.4% from the prior quarter.

Context

  • Change in working capital amounted to 25.3% of revenue in FY2025, up 22.2 pp from a year earlier.
  • Change in working capital increased in 2 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth recovers from -86.8% toward the trailing-twelve-month pace of +5.9%.

Sources:Cash FlowText generated from reported figures; not investment advice.

Latest quarterMar 2026
$1.95M-75.4% QoQ
Last fiscal yearDec 2025
$81.66M+318.4% YoY
LTMMar 2026
$68.86M+5.9% YoY
Change in Working Capital past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-86.8%——
1 year+318.4%——
3-year CAGR———
5-year CAGR——
10-year CAGR——

Change in Working Capital history

USD · from the cash flow

Latest · FY2025
81.66M USD
Year-over-year change
+318.4%

Change in Working Capital vs competitors

How DCGO compares with its peers on the latest reported figures

  • DCGO's LTM Mar 2026 change in working capital of $68.86M is the largest of the 9 companies compared; the peer median is $379K.
  • Its year-over-year change of +5.9% is the 4th highest of 9, against a peer median of -48.6%.
  • Change in working capital amounts to 22.8% of revenue for DCGO, versus a peer median of 10.2%.
DCGO Competitors Peer median
Change in Working Capital for DCGO and competitors
Company Period LTM YoY 3-year CAGR% of revenue
DCGODocGo Inc.LTM Mar 2026$68.86M +5.9%—22.8%
PRLDPrelude Therapeutics IncorporatedLTM Mar 2026$21.6M +725.2%+212.4%129.2%
MGNXMacroGenics, Inc.LTM Mar 2026$17.87M +67.2%+66.6%11.4%
MBOTMicrobot Medical Inc.LTM Mar 2026$1.86M -300.2%+64.1%1769.5%
RCELAVITA Medical, Inc.LTM Mar 2026$967K -46.5%—1.3%
COYACoya Therapeutics, Inc.LTM Mar 2026$721.9K -50.6%+72.8%9.1%
OVIDOvid Therapeutics Inc.LTM Mar 2026$469K -263.4%-20.7%6.6%
IMMXImmix Biopharma, Inc.LTM Mar 2026$301.74K -94.4%+140.1%—
VANIVivani Medical, Inc.LTM Mar 2026$289K +2123.1%-12.2%—
Peer median (excluding DCGO) $379K-48.6%+66.6%10.2%

Competitors are the stored peer set for DCGO. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Cash Flow Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income19.18M30.74M6.86M19.99M(196.37M)
Depreciation & Amortization7.07M10.57M16.43M15.88M15.66M
Deferred Income Tax(630.38K)(9.96M)(1.98M)3.47M7.75M
Stock-Based Compensation1.38M8.05M20.97M13.63M17.44M
Change in Working Capital(28.8M)(13.18M)(113.12M)19.52M81.66M
Accounts Receivables(58M)(8.42M)(160.52M)41.27M112.5M
Inventory00000
Accounts Payables11.88M3.64M(1.78M)8.56M(17.64M)
Other Working Capital17.31M(8.4M)49.18M(30.32M)(13.19M)
Other Non-Cash Items(142.67K)2.64M6.62M(2.16M)108.31M
Operating Cash Flow(1.95M)28.87M(64.22M)70.34M34.45M
Capital Expenditures(6.66M)(5.5M)(10.13M)(5.84M)(7.43M)
Acquisitions (Net)(1.96M)(32.95M)(19.46M)(310.45K)(16.4M)
Purchases of Investments(655.88K)00(5M)0
Sales of Investments655.88K00013.16M
Other Investing Activities(1.82M)(2.3M)(2.84M)(1.73M)(31.3M)
Investing Cash Flow(8.59M)(38.45M)(29.88M)(10.87M)(39.08M)
Debt Repayment(2.82M)(3.94M)20.7M613.55K(35.17M)
Common Stock Issued178.1M01.58M00
Common Stock Repurchased(479.33K)(3.73M)0(13.76M)(10.83M)
Dividends Paid000(1.29T)0
Other Financing Activities(19.6M)1.49M(21.17M)1.29T(4.82M)
Financing Cash Flow155.21M(6.18M)1.12M(24.15M)(50.82M)
Effect of Forex Changes(21.41K)761.23K1.09M(190.64K)595.8K
Net Change in Cash144.65M(15M)(91.89M)35.12M(54.85M)
Free Cash Flow(8.6M)23.37M(74.35M)64.5M27.02M

DocGo Inc.

NASDAQ:DCGO

Intrinsic Alpha fair value

Locked

Current Price

$0.71

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.